Glioblastoma (GB) stands out as the most prevalent and lethal form of brain cancer.
Although great efforts have been made by clinicians and researchers, no significant …

Tumour repopulation during treatment is a well acknowledged yet still challenging aspect of
cancer management. The latest research results show clear evidence towards the existence …

Background Sine oculis homeobox homolog 1 (SIX1) is a transcription factor that has
recently been identified as a crucial regulator of embryonic development and tumorigenesis …

Glioblastoma stem cells (GSCs) are pivotal in the recurrence and drug resistance of
glioblastoma multiforme (GBM). However, precision therapeutic and diagnostic markers for …

Patients with high-grade glioma (HGG) have an extremely poor prognosis compounded by a
lack of advancement in clinical care over the past few decades. Regardless of classification …

The precision medicine era has precipitated inherent new challenges to the preclinical
tumour biology field. Overall, continued poor clinical translatability of preclinical studies …

The key role of cancer stem cells (CSCs) in tumor development and therapy resistance
makes them essential biomarkers and therapeutic targets. Numerous agents targeting …

Developing novel nanomedicine formulations that successfully penetrate the blood-brain
barrier (BBB) to treat and diagnose glioma effectively is still a significant obstacle. This study …

Glioblastoma (GBM) is a highly aggressive and lethal type of brain tumor with complex and
diverse molecular signaling pathways involved that are in its development and progression …

Simple Summary Head and Neck Cancer is often diagnosed at an advanced stage, resulting
in poor long-term prognosis. Additionally, this cancer is resistant to chemotherapy. This …